CABA
USDCabaletta Bio Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$2.860
High
$2.970
Low
$2.630
Volume
3.67M
Company Fundamentals
Market Cap
247.0M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
3.63M
Exchange
NMS
Currency
USD
52-Week Range
Related News
Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
Rese-cel data presented at multiple medical meetings demonstrated potentially transformative, drug-free clinical responses with a favorable safety profile for autoimmune patients supporting outpatient use All myositis
FDA's Rigid Approach Adds Uncertainty To uniQure's Accelerated Pathway For Huntington's Gene Therapy
William Blair notes FDA's tougher stance on gene therapy programs as AMT-130 faces uncertainty in its accelerated approval timeline.
Cantor Fitzgerald Maintains Overweight on Cabaletta Bio, Raises Price Target to $30
Cantor Fitzgerald analyst Josh Schimmer maintains Cabaletta Bio with a Overweight and raises the price target from $15 to $30.
Cabaletta Bio Presents Positive Clinical Data and Development Updates for Rese-cel at ACR Convergence 2025
– All myositis patients in the Phase 1/2 DM/ASyS cohort with sufficient follow-up who met key registrational inclusion criteria exceeded the registrational primary endpoint, demonstrating major TIS responses with no
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.